Campbell & Co Investment Adviser’s Zymeworks ZYME Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Buy	54,883 +21,295	+63%	+$504K	0.08%	390
2025 Q4	$884K	Buy	33,588 +1,095	+3%	+$23.9K	0.04%	612
2025 Q3	$555K	Buy	32,493 +17,508	+117%	+$251K	0.04%	686
2025 Q2	$188K	Buy	+14,985	New	+$179K	0.01%	1064
2024 Q3	–	Sell	-30,363	Closed	-$258K	–	1379
2024 Q2	$258K	Buy	+30,363	New	+$270K	0.02%	885

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Campbell & Co Investment Adviser's ZYME Position: Q1 2026 in Review

Campbell & Co Investment Adviser increased its Zymeworks (ZYME) stake by 63% in Q1 2026, buying an estimated $504K and bringing the position to 54,883 shares worth $1.37M. The position accounts for 0.08% of the portfolio, ranked #390.

Campbell & Co Investment Adviser first reported a position in ZYME in Q2 2024 and has held it in 5 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

Campbell & Co Investment Adviser held 54,883 shares of Zymeworks worth $1.37M as of Q1 2026.
Campbell & Co Investment Adviser bought 21,295 Zymeworks shares in Q1 2026, an estimated $504K.
Zymeworks made up 0.08% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #390 holding.
Campbell & Co Investment Adviser first reported a position in Zymeworks in Q2 2024 and has held it in 5 quarters since.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.